首頁 > 市場調查報告書 > 製藥

開發平台分析

市場調查報告書

商品編碼

1402588

西尼羅河病毒市場：依產品類型、依管理途徑、依通路、地區

West Nile Virus Market, By Product Type, By Route of Administration, By Distribution Channel, By Region

出版日期: 2023年12月18日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

西尼羅河病毒市場規模預計將從 2023 年的 6.348 億美元增至 2030 年的 10.978 億美元，預測期內複合年成長率為 8.1%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	6.348 億美元
實際資料	2018-2021	預測期	2023-2030
預測期複合年成長率	8.10%	2030年市場規模預測	10.978 億美元

圖 1. 西尼羅河病毒全球市場佔有率(%)，依地區分類，2023 年

西尼羅河病毒 (WNV) 是一種由蚊子傳播的疾病，可感染人類、鳥類和其他動物。它於 1937 年首次在烏干達西尼羅河地區被發現，此後已傳播到世界其他地區，包括北美、歐洲和亞洲。該病毒主要透過受感染的蚊子叮咬傳播給人類。西尼羅河病毒可引起多種症狀，從輕微的類流感症狀到嚴重的神經系統疾病，如腦炎和腦膜炎。大多數感染者不會表現出任何症狀，但約 20% 的人可能會發燒、頭痛、身體疼痛、噁心、嘔吐和皮疹。在極少數情況下，西尼羅河病毒可能致命。

市場動態：

全球西尼羅河病毒市場受到多種因素的推動。西尼羅河病毒感染發生率的上升，特別是在北美和歐洲，是市場成長的主要驅動力之一。此外，提高對該疾病及其預防和診斷的認知也有助於市場擴張。例如，根據美國疾病管制與預防中心（CDC）的資料，向國家監測系統報告的西尼羅病毒神經侵襲性疾病病例將從2021年的2000多例增加到2022年的2500多例。。做過。德克薩斯州、加利福尼亞州、路易斯安那州、內布拉斯加州和伊利諾伊州等州的病例數量最多。該病毒的傳播可能是由於氣候變遷引起的氣溫升高、感染季節延長以及傳播病毒的蚊子的地理範圍擴大所致。

然而，也存在阻礙市場成長的因素。對抗西尼羅河病毒的一個主要課題是有效治療方法和疫苗的供應有限。與診斷和治療相關的高成本進一步阻礙了市場成長。

儘管面臨這些課題，市場參與企業仍有機會找到前進的道路。新興經濟體的高成長潛力、有效治療方法方法的開發以及蚊蟲控制方法的更多利用帶來了巨大的成長機會。製藥公司和研究機構之間的合作還可以加速西尼羅河病毒創新解決方案的發展。

本研究的主要特點

該報告對全球西尼羅河病毒市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
本報告還闡明了不同區隔市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
本報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
本報告根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球西尼羅河病毒市場的主要企業。
該報告的見解使行銷人員和經營團隊負責人就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球西尼羅病毒市場的各種策略矩陣來促進他們的決策。

北美洲
美國
加拿大
歐洲
德國
英國
法國
西班牙
義大利
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
亞太地區其他國家
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲
中東
2018-2030 年市場規模與依產品類型預測、與前一年同期比較成長率
2018-2030 年市場規模與依管理途徑預測、與前一年同期比較成長率
2018-2030年依通路分類的市場規模與預測、與前一年同期比較成長率
2018-2030 年市場規模及各國預測、與前一年同期比較成長率
GCC
以色列
其他中東地區
非洲
2018-2030 年市場規模與依產品類型預測、與前一年同期比較成長率
2018-2030 年市場規模與依管理途徑預測、與前一年同期比較成長率
2018-2030年依通路分類的市場規模與預測、與前一年同期比較成長率
2018-2030年依國家/地區與前一年同期比較成長率
南非
北非
中部非洲

第9章競爭形勢

Sanofi
Pfizer
GlaxoSmithKline
Merck
AstraZeneca
Johnson & Johnson
F.Hoffmann-La Roche
Novartis
Cipla
Gilead Sciences

第10章

調查方法
關於出版商

簡介目錄

Product Code: CMI6235

The West Nile virus market size is expected to reach US$$ 1,097.8 Mn by 2030, from US$ 634.8 million in 2023, at a CAGR of 8.1% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 634.8 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	8.10%	2030 Value Projection:	US$ 1,097.8 Mn

Figure 1. Global West Nile Virus Market Share (%), by Region, 2023

West Nile virus (WNV) is a mosquito-borne disease that affects humans, birds, and other animals. It was first identified in the West Nile region of Uganda in 1937 and has since spread to many parts of the world, including North America, Europe, and Asia. The virus is primarily transmitted to humans through the bite of infected mosquitoes. WNV can cause a range of symptoms, from mild flu-like illness to severe neurologic diseases such as encephalitis and meningitis. While most infected individuals do not develop any symptoms, around 20% may experience fever, headache, body aches, nausea, vomiting, and rash. In rare cases, WNV can be fatal.

Market Dynamics:

The global West Nile virus market is driven by various factors. The rising incidence of WNV infections, especially in North America and Europe, is one of the primary drivers of market growth. Increasing awareness about the disease, its prevention, and diagnostics is also contributing to market expansion. For instance, according to data from the Centers for Disease Control and Prevention (CDC), the number of West Nile virus neuroinvasive disease cases reported to the national surveillance system increased from over 2000 cases in 2021 to over 2500 cases in 2022. States such as Texas, California, Louisiana, Nebraska, and Illinois witnessed the highest number of cases. The growing prevalence of the virus can be attributed to rising temperatures linked to climate change that are extending the transmission season and expanding the geographical range of mosquitoes that can spread the virus.

However, there are certain restraints hampering the growth of the market. The limited availability of effective treatments and vaccines is a major challenge in combating WNV. High costs associated with diagnosis and treatment further hinder market growth.

Despite these challenges, there are opportunities for market players to capitalize on. High growth potential in emerging economies, development of effective treatment options and rising usage of mosquito control methods presents a significant opportunity for growth. In addition, collaborations between pharmaceutical companies and research institutes can accelerate the development of innovative solutions for WNV.

Key features of the study:

This report provides in-depth analysis of the global West Nile virus market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global West Nile virus market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Sanofi, Pfizer, GlaxoSmithKline, Merck, AstraZeneca, Johnson & Johnson, F. Hoffmann-La Roche, Novartis, Cipla, and Gilead Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global West Nile virus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global West Nile virus market

Detailed Segmentation:

By Product Type:
- Antivirals
- Vaccines
- Antibiotics
- Analgesics
- Others (Immunoglobulins and among Others)
By Route of Administration:
- Oral
- Injectable
- Topical
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Company Profiles:
- Sanofi
- Pfizer
- GlaxoSmithKline
- Merck
- AstraZeneca
- Johnson & Johnson
- F.Hoffmann-La Roche
- Novartis
- Cipla
- Gilead Scienes

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global West Nile Virus Market, By Product Type
- Global West Nile Virus Market, By Route of Administration
- Global West Nile Virus Market, By Distribution Channel
- Global West Nile Virus Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
Epidemiology
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global West Nile Virus Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global West Nile Virus Market, By Product Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global West Nile Virus Market, By Route of Administration , 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Mn)

7. Global West Nile Virus Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

8. Global West Nile Virus Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
Germany
U.K.
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of APAC
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Sanofi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GlaxoSmithKline
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Merck
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
AstraZeneca
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Johnson & Johnson
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
F.Hoffmann-La Roche
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Novartis
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Cipla
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Gilead Sciences
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

西尼羅河病毒市場：依產品類型、依管理途徑、依通路、地區

West Nile Virus Market, By Product Type, By Route of Administration, By Distribution Channel, By Region

市場動態：

本研究的主要特點

目錄

第1章研究目的與前提

第2章市場展望

第3章市場動態、法規及趨勢分析

第4章全球西尼羅河病毒市場－冠狀病毒（COVID-19）大流行的影響

第5章全球西尼羅河病毒市場，依產品類型，2018-2030

第6章全球西尼羅河病毒市場，依管理途徑，2018-2030 年

第7章全球西尼羅河病毒市場，依通路，2018-2030

第8章全球西尼羅河病毒市場，依地區，2018-2030

第9章競爭形勢

第10章

Market Dynamics:

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global West Nile Virus Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global West Nile Virus Market, By Product Type, 2018-2030, (US$ Mn)

6. Global West Nile Virus Market, By Route of Administration , 2018-2030, (US$ Mn)

7. Global West Nile Virus Market, By Distribution Channel, 2018-2030, (US$ Mn)

8. Global West Nile Virus Market, By Region, 2018-2030, (US$ Mn)

9. Competitive Landscape

10. Section

西尼羅河病毒市場：依產品類型、依管理途徑、依通路、地區

West Nile Virus Market, By Product Type, By Route of Administration, By Distribution Channel, By Region

市場動態：

本研究的主要特點

目錄

第1章 研究目的與前提

第2章 市場展望

第3章市場動態、法規及趨勢分析

第4章全球西尼羅河病毒市場－冠狀病毒（COVID-19）大流行的影響

第5章全球西尼羅河病毒市場，依產品類型，2018-2030

第6章 全球西尼羅河病毒市場，依管理途徑，2018-2030 年

第7章 全球西尼羅河病毒市場，依通路，2018-2030

第8章全球西尼羅河病毒市場，依地區，2018-2030

第9章 競爭形勢

第10章

Market Dynamics:

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global West Nile Virus Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global West Nile Virus Market, By Product Type, 2018-2030, (US$ Mn)

6. Global West Nile Virus Market, By Route of Administration , 2018-2030, (US$ Mn)

7. Global West Nile Virus Market, By Distribution Channel, 2018-2030, (US$ Mn)

8. Global West Nile Virus Market, By Region, 2018-2030, (US$ Mn)

9. Competitive Landscape

10. Section

第1章研究目的與前提

第2章市場展望

第6章全球西尼羅河病毒市場，依管理途徑，2018-2030 年

第7章全球西尼羅河病毒市場，依通路，2018-2030

第9章競爭形勢